A detailed history of Cerity Partners LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 16,759 shares of KOD stock, worth $139,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,759
Holding current value
$139,434
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.2 - $3.25 $36,869 - $54,466
16,759 New
16,759 $43,000
Q1 2024

May 14, 2024

BUY
$3.01 - $7.45 $45,499 - $112,614
15,116 New
15,116 $79,000
Q3 2021

Oct 25, 2021

SELL
$81.97 - $106.94 $452,802 - $590,736
-5,524 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$77.2 - $126.54 $40,452 - $66,306
524 Added 10.48%
5,524 $514,000
Q1 2021

Aug 11, 2021

BUY
$110.45 - $164.47 $552,250 - $822,350
5,000 New
5,000 $567,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $433M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.